Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ALOX15
REST API REST API
Homo sapiens
ALOX15 is differentially expressed in 169 experiments: 70 organism parts: trachea, lung, ... (68 more);, 84 disease states: normal, prostate carcinoma, ... (82 more);, 50 cell types 124 cell lines 23 compound treatments and 61 other conditions.
Synonyms 15-LOX-1
Orthologs F1MCH9_BOVIN (Bos taurus)   Alox15 (Mus musculus)   Alox15 (Rattus norvegicus)   ALOX15 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, oxidoreductase activity, leukotriene biosynthetic process, protein binding, iron ion binding, cytoplasm, metal ion binding, oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen, lipid metabolic process, nucleus, lipoxygenase activity, bone mineralization, arachidonate 15-lipoxygenase activity, ossification, arachidonate 12-lipoxygenase activity, leukotriene metabolic process, hepoxilin-epoxide hydrolase activity, inflammatory response, lipoxygenase pathway, oxidation-reduction process
InterPro Term LipOase_LH2, LipOase_C, LipOase_mml
UniProt Accession P16050, D3DTK1, F5H0G8
Search EB-eye ENSG00000161905
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MTAB-24, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-1309, E-GEOD-1880, E-GEOD-14464, ... (23 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-20081, E-GEOD-19639, E-GEOD-3529, E-GEOD-5823
BT-474
2
E-GEOD-5823, E-GEOD-3529
LNCaP
2
E-GEOD-14990, E-GEOD-14464
MCF-10A
2
E-GEOD-14990, E-TABM-420
HMEC
1
E-GEOD-29119
MKN1
1
E-GEOD-15460
118 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-GEOD-360, E-GEOD-13987, ... (29 experiments)

Factor Value U/D Experiments
mast cell
1
E-GEOD-3982
leydig cell
1
E-MTAB-25
primary human mammary epithelial cells
1
E-GEOD-29119
hematopoietic progenitor cells
1
E-MEXP-70
CD19+ B cell
1
E-MEXP-1600
n/a
1
E-MTAB-24
44 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-20602, E-GEOD-9692, E-MEXP-121, ... (27 experiments)

Factor Value U/D Experiments
colon carcinoma
2
E-MTAB-62, E-MTAB-37
control
2
E-GEOD-8121, E-GEOD-20602
prostate carcinoma
1
2
E-MTAB-62, E-GEOD-3868, E-MTAB-37
head and neck squamous cell carcinoma
1
E-MTAB-62
engineered non-invasive esophageal squamous cell carcinoma
1
E-GEOD-21293
atopic mild asthmatics
1
E-MTAB-62
78 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-1417, E-GEOD-5824, E-GEOD-5099, E-MEXP-1958, ... (15 experiments)

Factor Value U/D Experiments
none
3
5
E-MEXP-1958, E-GEOD-412, E-GEOD-5824, E-GEOD-2803, E-MEXP-1230, ... (8 experiments)
vanadium pentoxide
1
E-GEOD-5339
M-CSF
1
E-GEOD-5099
sevoflurane
1
E-GEOD-4386
baseline sevoflurane
1
E-GEOD-4386
granulocyte macrophage-colony stimulating factor
1
E-GEOD-2803
17 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Chromosomal aberration
studied in E-GEOD-1729

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-5999, E-GEOD-3140, E-MEXP-2359, E-GEOD-3891, E-MTAB-62 ... (5 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-TABM-147, E-GEOD-3013

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-4006

Genotype
studied in E-GEOD-22056, E-GEOD-17476, E-TABM-321, E-TABM-601, E-GEOD-3790, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-1446, E-MEXP-2146

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-666, E-GEOD-19519, E-GEOD-6919, ... (24 experiments)

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-AFMX-1, E-TABM-84

Performer
studied in E-GEOD-2004

Phenotype
studied in E-GEOD-22309

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19445

RNAi
studied in E-MEXP-101

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Vehicle
studied in E-GEOD-5258

Processing time: 0.255 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM